ARE WE READY TO INDICATE MYELODYSPLASTIC SYNDROME PATIENTS TO HEMATOPOIETIC STEM CELL TRANSPLANTATION BASED ON THEIR GENETIC STATUS?

Authors

  • Mair Pedro de Souza
  • Fernanda Leite Souza Franceschi
  • Fernando Barroso Duarte
  • Diego Coutinho
  • Beatrice Araujo Duarte
  • Romelia Pinheiro Gonçalves Lemes
  • Vergilio Colturato

DOI:

https://doi.org/10.46765/2675-374X.2020v2n1p16-19

Abstract

Mielodysplastic syndrome and hematopoietic stem cell transplantation based on genetic status.

Downloads

Published

10/14/2020

How to Cite

de Souza, M. P., Franceschi, F. L. S., Duarte, F. B., Coutinho, D., Duarte, B. A., Lemes, R. P. G., & Colturato, V. (2020). ARE WE READY TO INDICATE MYELODYSPLASTIC SYNDROME PATIENTS TO HEMATOPOIETIC STEM CELL TRANSPLANTATION BASED ON THEIR GENETIC STATUS?. JOURNAL OF BONE MARROW TRANSPLANTATION AND CELLULAR THERAPY, 1(3), 16–19. https://doi.org/10.46765/2675-374X.2020v2n1p16-19

Issue

Vol. 1 No. 3 (2020): Journal of Bone Marrow Transplantation and Cellular Therapy

Section

Original article